Susan Slaugenhaupt, PhD
"The Biobank will give patients the power to partner with their physicians and leading scientists to discover important new insights into complex disease that will change how we practice medicine in the future." - Susan Slaugenhaupt
Susan Slaugenhaupt received her PhD in Human Genetics from the University of Pittsburgh in Pittsburgh, PA, USA. She is a Principal Investigator in the Center for Human Genetic Research (CHGR) at Massachusetts General Hospital (MGH), Professor at Harvard Medical School and Geneticist in the Department of Neurology/Molecular Neurogenetics Unit at MGH. The overall goal of the Slaugenhaupt lab is to bring the study of genetic disease full circle: from the initial collection of family data, to the cloning and characterization of the culprit gene, and back to the patient via development of improved diagnostics and effective therapies. Dr. Slaugenhaupt’s work focuses on familial dysautonomia (FD), mucolipidosis type IV (MLIV), and mitral valve prolapse. With her leadership, the Slaugenhaupt lab has made tremendous advances in understanding the genetic basis of these disorders and translating these discoveries into potential therapies. Most recently, Dr. Slaugenhaupt was named the inaugural Scientific Director of the MGH Research Institute.